WHO GMP Approved Manufacturing Facility, BP, DMF, Derivative of Vitamin D, Antipsoriatic.
Calcipotriene, used to treat psoriasis in humans, is available as an ointment or cream (0.005% or 50 µgg). Calcipotriene is a novel structural analog of calcitriol (1,25-dihydroxycholecalciferol), the most active metabolite of cholecalciferol (vitamin D3). Accidental ingestion of 40-60 µgkg of calcipotriene in dogs has been associated with life-threatening hypercalcemia. Clinical signs usually occur within 24-72 hr of ingestion and include anorexia, vomiting, diarrhea, polyuria, polydipsia, depression, and weakness. Serum calcium is usually elevated within 12-24 hr and may remain above normal for weeks. This is usually accompanied by an increase in serum phosphorous concentration and calcium phosphorous product (Ca × P) and soft tissue mineralization.

WHO GMP Approved Manufacturing Facility, BP, DMF, Derivative of Vitamin D, Antipsoriatic.
Calcipotriene, used to treat psoriasis in humans, is available as an ointment or cream (0.005% or 50 µgg). Calcipotriene is a novel structural analog of calcitriol (1,25-dihydroxycholecalciferol), the most active metabolite of cholecalciferol (vitamin D3). Accidental ingestion of 40-60 µgkg of calcipotriene in dogs has been associated with life-threatening hypercalcemia. Clinical signs usually occur within 24-72 hr of ingestion and include anorexia, vomiting, diarrhea, polyuria, polydipsia, depression, and weakness. Serum calcium is usually elevated within 12-24 hr and may remain above normal for weeks. This is usually accompanied by an increase in serum phosphorous concentration and calcium phosphorous product (Ca × P) and soft tissue mineralization.